• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4593338)   Today's Articles (5509)   Subscriber (49320)
For: van Griensven JM, Jusko WJ, Lemkes HH, Kroon R, Verhorst CJ, Chiang ST, Cohen AF. Tolrestat pharmacokinetic and pharmacodynamic effects on red blood cell sorbitol levels in normal volunteers and in patients with insulin-dependent diabetes. Clin Pharmacol Ther 1995;58:631-40. [PMID: 8529328 DOI: 10.1016/0009-9236(95)90019-5] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Number Cited by Other Article(s)
1
Singh M, Kapoor A, Bhatnagar A. Physiological and Pathological Roles of Aldose Reductase. Metabolites 2021;11:655. [PMID: 34677370 PMCID: PMC8541668 DOI: 10.3390/metabo11100655] [Citation(s) in RCA: 33] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2021] [Revised: 09/17/2021] [Accepted: 09/17/2021] [Indexed: 12/15/2022]  Open
2
Elinson MN, Ryzhkova YE, Vereshchagin AN, Ryzhkov FV, Egorov MP. Electrocatalytic multicomponent one‐pot approach to tetrahydro‐2′ H , 4 H ‐spiro[benzofuran‐2,5′‐pyrimidine] scaffold. J Heterocycl Chem 2021. [DOI: 10.1002/jhet.4274] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
3
Fan J, de Lannoy IA. Pharmacokinetics. Biochem Pharmacol 2014;87:93-120. [DOI: 10.1016/j.bcp.2013.09.007] [Citation(s) in RCA: 169] [Impact Index Per Article: 16.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2013] [Revised: 09/06/2013] [Accepted: 09/09/2013] [Indexed: 11/29/2022]
4
Cohen A. Pharmacokinetic and Pharmacodynamic Data to be Derived from Early-Phase Drug Development. Clin Pharmacokinet 2008;47:373-81. [DOI: 10.2165/00003088-200847060-00002] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
5
Dingemanse J, Appel-Dingemanse S. Integrated pharmacokinetics and pharmacodynamics in drug development. Clin Pharmacokinet 2007;46:713-37. [PMID: 17713971 DOI: 10.2165/00003088-200746090-00001] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
6
Chung P, McNamara PJ, Campion JJ, Evans ME. Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother 2006;50:2957-65. [PMID: 16940088 PMCID: PMC1563538 DOI: 10.1128/aac.00736-05] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open
7
Yao Z, Krzyzanski W, Jusko WJ. Assessment of Basic Indirect Pharmacodynamic Response Models with Physiological Limits. J Pharmacokinet Pharmacodyn 2006;33:167-93. [PMID: 16547797 DOI: 10.1007/s10928-006-9003-7] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
8
Lin S, Chien YW. Pharmacokinetic-pharmacodynamic modelling of insulin: comparison of indirect pharmacodynamic response with effect-compartment link models. J Pharm Pharmacol 2002;54:791-800. [PMID: 12078995 DOI: 10.1211/0022357021779131] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
9
Sharma A, Jusko WJ. Characteristics of indirect pharmacodynamic models and applications to clinical drug responses. Br J Clin Pharmacol 1998;45:229-39. [PMID: 9517366 PMCID: PMC1873365 DOI: 10.1046/j.1365-2125.1998.00676.x] [Citation(s) in RCA: 148] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/1997] [Accepted: 10/22/1997] [Indexed: 02/06/2023]  Open
10
Renwick AG, Lazarus NR. Human variability and noncancer risk assessment- An analysis of the default uncertainty factor. Regul Toxicol Pharmacol 1998;27:3-20. [PMID: 9618319 DOI: 10.1006/rtph.1997.1195] [Citation(s) in RCA: 197] [Impact Index Per Article: 7.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
11
van Schaick EA, de Greef HJ, Ijzerman AP, Danhof M. Physiological indirect effect modeling of the antilipolytic effects of adenosine A1-receptor agonists. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS 1997;25:673-94. [PMID: 9697077 DOI: 10.1023/a:1025777700413] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
12
van Schaick EA, de Greef HJ, Langemeijer MW, Sheehan MJ, IJzerman AP, Danhof M. Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulphophenyl)adenosine in rats. Br J Pharmacol 1997;122:525-33. [PMID: 9351510 PMCID: PMC1564970 DOI: 10.1038/sj.bjp.0701412] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]  Open
13
Fruncillo R, Troy S, Parker V, Mayersohn M, Hicks D, Kraml M, Battle M, Chiang S. Pharmacokinetics of the aldose reductase inhibitor tolrestat: studies in healthy young and elderly male and female subjects and in subjects with diabetes. Clin Pharmacol Ther 1996;59:603-12. [PMID: 8681485 DOI: 10.1016/s0009-9236(96)90000-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA